Bruce Cooper

Dr. Bruce Cooper is biopharma physician-leader and entrepreneur with decades of experience in US and Global Medical Affairs, drug/device development, reimbursement and commercialization. Bruce has demonstrated success in start-up, specialty and large Pharma across a broad range of therapeutic areas and has been particularly instrumental in developing high performing leaders and organizations with a bias for action and innovation.

Bruce is currently Managing Director of VIANZUS LLC, a consulting company. Prior to this, his distinguished career highlights include various leadership roles in medical affairs, company general management, strategic marketing, clinical development and regulatory affairs, pricing and reimbursement, business development and change management at global companies like AstraZeneca, Roche/Genentech, CorMedix, the Medicines Company, and Sanofi Aventis.

Bruce continues to use his skills and expertise advising companies who aim to bring transformative therapies to patients and is very excited about the potential for cytotoxic CD8+ T lymphocytes to cure serious infection and other diseases like cancer.

Privately, as a resident of New York City, Bruce is a passionate supporter of the arts as a Patron of the Metropolitan Opera, New York Philharmonic and a number of Off-Broadway theaters. He also enjoys the challenge of growing tropical plants on his Manhattan terrace.

Bruce received his Medical Training and Degrees (MBChB, BHB) and post graduate training in clinical microbiology at University of Auckland Medical School in New Zealand.